Trevi Therapeutics Raises $10M Series A
Trevi Therapeutics Inc., a a drug development company founded in 2011, has raised $10 million in Series A financing. TPG Biotech provided the financing, the company said.
18 December 2012•2 mins read
Trevi Therapeutics Inc., a a drug development company founded in 2011, has raised $10 million in Series A financing. TPG Biotech provided the financing, the company said.
